$NVO Semaglutide in NASH P2 +ve for all 3 doses. Resolution of NASH + no worsening in fibrosis 59% for high dose vs 17% for placebo @ 72 wks. Comparatively $NGM FGF19 @ WK 24 24% vs 9% $ICPT $MDGL $VKTX $AKRO
Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: https://t.co/sz7RYbLFmH #mRNA
#Breaking: Pivotal data evaluating spinal muscular atrophy (SMA) medicine shows study met its primary endpoint in infants with Type 1 #SMA. https://t.co/iQFNIXQWNP
#COVID19 $GILD Japan's Prime Minister, Shinzō Abe, says coronavirus drug candidate remdesivir may soon be granted special approval.
https://t.co/65ojBWntLZ
A mass testing in the Italian town of Vo’ Euganeo, in the northeast of Italy, found more than 40% of those infected had no symptoms https://t.co/dQQYQiGePb
$AZN $MRK Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer https://t.co/c1fzfEmEMu